BAC vs ITCI Stock Comparison
ITCI currently leads BAC in this stock comparison, with AIQ scores of 54 vs 47. The clearest difference is risk resilience, while BAC has the stronger value profile.
What is the main difference between BAC and ITCI?
ITCI leads the current stock comparison as Intra-Cellular Therapies, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Bank of America Corporation vs Intra-Cellular Therapies, Inc.
ITCI leads
ITCI leads by 7 AIQ points, primarily on Risk Resilience and Quality, but the lead has narrowed from 13 points over 30 sessions. Wall Street currently favors BAC on target upside.
Competitive: 3 of 5 evidence groups support ITCI, and its lead is narrowing.
Bank of America Corporation
Intra-Cellular Therapies, Inc.
The Algovestiq AIQ Score currently favors ITCI over BAC, 54 versus 47 as of Oct 31, 2026. ITCI's advantage is driven primarily by stronger risk resilience and quality, while BAC holds the stronger value profile. Analyst target upside, however, currently favors BAC. 3 of 5 covered evidence groups favor ITCI today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. ITCI lead: Weakening — the AIQ differential moved from 13 to 7 points over 30 sessions.
Compare Bank of America Corporation and Intra-Cellular Therapies, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BAC and ITCI against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value57 vs 34BAC +23
- Risk Resilience60 vs 82ITCI +22
- Quality49 vs 60ITCI +11
3 of 5 evidence groups favor ITCI. ITCI’s edge is concentrated in risk resilience and quality; BAC keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Risk Resilience +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
No factor moved materially.
No signal started or stopped since the prior session.
ITCI's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — BAC and ITCI both carry a full feed there.
The central trade-off
ITCI (Intra-Cellular Therapies, Inc.): the stronger current systematic profile, led by risk resilience and quality.
BAC (Bank of America Corporation): the counter-case, on value, valuation, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ITCIITCI on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
ITCIITCI on combined revenue and EPS growth.
Value
BACBAC on the peer-relative Value factor, by 23 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
ITCIITCI on Risk Resilience, by 22 points.
Analyst upside
BACBAC on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ITCI, analyst targets favor BAC. That disagreement is the most useful thing on this page.
| Measure | BAC | ITCI | Note |
|---|---|---|---|
| Implied upside to target | +32.5% | +0.1% | BAC has more room |
| Target dispersion | +22.6% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 11 | 1 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor ITCI. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ITCI | 47 vs 54 |
| Fundamentals | ITCIon balance | revenue growth -3.3% vs 13.7%; EPS growth -23.8% vs 3.2%; TTM ROE 10.7% vs -8.6%; gross margin 60.4% vs 91.6%; operating margin 22.4% vs -17.1% — ITCI takes 3 of 5 decided legs, not all of them |
| Valuation | BAC | Value 57 vs 34 |
| Technicals | Not covered | Not covered |
| Risk Resilience | ITCI | Risk Resilience 60 vs 82 |
| Analyst expectations | BAC | Target upside 32.5% vs 0.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and ITCI and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 7 points.
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ITCI.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28ITCI lead: Weakening — the AIQ differential moved from 13 to 7 points over 30 sessions.
- Today
- ITCI +7
- 47 vs 54
- 7 sessions ago
- ITCI +7
- 47 vs 54
- 30 sessions ago
- ITCI +13
- 41 vs 54
- 90 sessions ago
- ITCI +7
- 50 vs 57
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish / 1 neutral
Only BAC
- Bollinger Band Squeeze — neutral, volatility, short horizon
- Golden Cross Active — bullish, trend, long horizon (3.51%)
- MACD Bullish Crossover — bullish, momentum, short horizon
No active signals
No signal that the other name lacks.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.21%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BAC closes the Risk Resilience gap — currently 22 points behind, the largest single contributor to ITCI's edge.
- 2BAC's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3ITCI starts generating bearish momentum or trend signals.
- 4The narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 7-point move would eliminate ITCI's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
ITCI leads on balance| Metric | BAC | ITCI |
|---|---|---|
| Revenue growth (YoY) | -3.3% | 13.7% |
| EPS growth (YoY) | -23.8% | 3.2% |
| Gross margin | 60.4% | 91.6% |
| Operating margin | 22.4% | -17.1% |
| Return on equity (TTM) | 10.7% | -8.6% |
| Debt to equity | 1.28 | 0.01 |
Performance
Split across windows| Metric | BAC | ITCI |
|---|---|---|
| 1 week (5 sessions) | 0.1% | — |
| 1 month (20 sessions) | -6.6% | — |
| 3 months (63 sessions) | -17.6% | — |
| 6 months (126 sessions) | -3.8% | — |
| Year to date | -7.5% | — |
| 1 year (252 sessions) | -3.3% | — |
Technicals
Split| Metric | BAC | ITCI |
|---|---|---|
| RSI (14) | 31.2 | — |
| ADX (14) | 49.4 | — |
| Price vs 50-day | -12.1% | — |
| Price vs 200-day | -7.5% | — |
| Volatility (1M, annualized) | 20.8% | — |
Risk
ITCI is the more resilient| Metric | BAC | ITCI |
|---|---|---|
| Beta | 0.73 | — |
| Sharpe ratio | -0.25 | — |
| Sortino ratio | -0.32 | — |
| Max drawdown | -22.3% | — |
| Current drawdown | -21.5% | — |
| Annualized volatility | 21.8% | — |
| Value at risk (95%) | -2.5% | — |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BAC or ITCI?
On the Algovestiq AIQ Score, ITCI is the stronger of the two as of Oct 31, 2026, scoring 54 against BAC's 47. The edge comes from risk resilience and quality. BAC is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BAC or ITCI the better buy right now?
ITCI carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor ITCI over BAC?
The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Value by 23 points; ITCI leads Risk Resilience by 22 points; ITCI leads Quality by 11 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BAC or ITCI?
Analyst price targets imply +32.5% upside for BAC and +0.1% for ITCI, so the Street currently favors BAC. That points the opposite way to the AIQ Score, which favors ITCI. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BAC or ITCI?
BAC is the better-valued of the two on the peer-relative Value factor. BAC on the peer-relative Value factor, by 23 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BAC or ITCI?
ITCI on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BAC or ITCI?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BAC or ITCI?
ITCI is the more resilient of the two, so the other name carries the higher downside risk. ITCI on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BAC more profitable than ITCI?
The profitability evidence is mixed: gross margin 60.4% vs 91.6%; operating margin 22.4% vs -17.1%; ttm roe 10.7% vs -8.6%. BAC leads on two measures and ITCI on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is ITCI's lead over BAC getting stronger or weaker?
ITCI lead: Weakening — the AIQ differential moved from 13 to 7 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has not changed hands in that window.
What would change the BAC vs ITCI verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Risk Resilience gap — currently 22 points behind, the largest single contributor to ITCI's edge; BAC's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; ITCI starts generating bearish momentum or trend signals; the narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 7-point move would eliminate ITCI's advantage entirely.
What do the current signals say about BAC and ITCI?
BAC: 2 bullish / 0 bearish / 1 neutral. ITCI: No active signals. The most decision-relevant rule on BAC is Golden Cross Active (bullish, long horizon).
Compare BAC and ITCI with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.